Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong · Delayed Price · Currency is HKD 48.42
-1.30 (-2.61%)
Jul 9, 2026, 4:08 PM HKT
Nanjing Leads Biolabs Market Cap
Nanjing Leads Biolabs has a market cap or net worth of 9.63 billion as of July 9, 2026.
Market Cap
9.63B
Enterprise Value
8.22B
Revenue
197.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
48.42
Market Cap Chart
Since July 25, 2025, Nanjing Leads Biolabs's market cap has decreased from 12.97B to 9.63B, a decrease of -25.78%. That is a compound annual growth rate of -26.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 9.63B | -5.06% |
| Dec 31, 2025 | 10.14B | -21.82% |
| Jul 25, 2025 | 12.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GenFleet Therapeutics (Shanghai) | 12.65B |
| Ascletis Pharma | 12.24B |
| TenNor Therapeutics (Suzhou) | 10.17B |
| HBM Holdings | 9.92B |
| Everest Medicines | 9.62B |
| CARsgen Therapeutics Holdings | 9.10B |
| Suzhou Ribo Life Science | 8.85B |
| CStone Pharmaceuticals | 8.55B |